Sold as Tolinase, Tolazamide. Every FDA application for this active ingredient: 2 branded and 29 generic.
As of Nov 16, 2026, FDA lists 31 applications for Tolazamide (sold as Tolinase, Tolazamide), first approved Jul 18, 1966, with 0 new uses approved and 0 published complete response letters.
| Jul 18, 1966 | TolinaseNDA 15500 · New molecular entity | Pharmacia And Upjohn | 9 | Discontinued |
| Oct 3, 1984 | TolazamideNDA 18894 | Cosette | 11 | Discontinued |
| Jan 6, 1986 | TolazamideANDA 70160 | Par Pharm | 6 | Discontinued |
| Jan 6, 1986 | TolazamideANDA 70161 | Par Pharm | 6 | Discontinued |
| Jan 6, 1986 | TolazamideANDA 70159 | Par Pharm | 6 | Discontinued |
| Jan 9, 1986 | TolazamideANDA 70513 | Watson Labs | 8 | Discontinued |
| Jan 9, 1986 | TolazamideANDA 70514 | Watson Labs | 8 | Discontinued |
| Jan 9, 1986 | TolazamideANDA 70515 | Watson Labs | 8 | Discontinued |
| Jan 10, 1986 | TolazamideANDA 70165 | Duramed Pharms Barr | 2 | Discontinued |
| Jan 10, 1986 | TolazamideANDA 70167 | Duramed Pharms Barr | 2 | Discontinued |
| Jan 14, 1986 | TolazamideANDA 70162 | Barr | 2 | Discontinued |
| Jan 14, 1986 | TolazamideANDA 70163 | Barr | 2 | Discontinued |
| Jan 14, 1986 | TolazamideANDA 70164 | Barr | 2 | Discontinued |
| Mar 13, 1986 | TolazamideANDA 70289 | Chartwell Rx | 11 | Discontinued |
| Mar 13, 1986 | TolazamideANDA 70290 | Chartwell Rx | 10 | Discontinued |
| Jun 16, 1986 | TolazamideANDA 70763 | Superpharm | 0 | Discontinued |
| Nov 7, 1986 | TolazamideANDA 70259 | Natco | 13 | Discontinued |
| Jul 16, 1987 | TolazamideANDA 71357 | Sun Pharm Industries | 9 | Discontinued |
| Jul 16, 1987 | TolazamideANDA 71358 | Sun Pharm Industries | 11 | Discontinued |
| Jul 16, 1987 | TolazamideANDA 71359 | Sun Pharm Industries | 11 | Discontinued |
| Dec 9, 1987 | TolazamideANDA 71633 | Chartwell Rx | 8 | Discontinued |
| — | TolazamideANDA 70166 | Duramed Pharms Barr | 0 | Discontinued |
| — | TolazamideANDA 70168 | Usl Pharma | 0 | Discontinued |
| — | TolazamideANDA 70169 | Usl Pharma | 0 | Discontinued |
| — | TolazamideANDA 70242 | Watson Labs | 0 | Discontinued |
| — | TolazamideANDA 70243 | Watson Labs | 0 | Discontinued |
| — | TolazamideANDA 70244 | Watson Labs | 0 | Discontinued |
| — | TolazamideANDA 70764 | Superpharm | 0 | Discontinued |
| — | TolazamideANDA 71270 | Interpharm | 0 | Discontinued |
| — | TolazamideANDA 71271 | Interpharm | 0 | Discontinued |
| — | TolazamideANDA 71355 | Usl Pharma | 0 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA